Three-year U.S. pharmacovigilance report of brodalumab.
Lebwohl M, Leonardi C, Armstrong A, Rawnsley N, Alexander B, Goehring E Jr, Kerdel F, Jacobson A.
Lebwohl M, et al. Among authors: leonardi c.
Dermatol Ther. 2021 Nov;34(6):e15105. doi: 10.1111/dth.15105. Epub 2021 Sep 5.
Dermatol Ther. 2021.
PMID: 34418244
Free PMC article.